VYNE Therapeutics, Inc. (VYNE)
0.41
+0.03
(+8.81%)
USD |
NASDAQ |
Dec 10, 13:39
VYNE Therapeutics Profit Margin (Quarterly): -4.39K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | 18.08% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
| Palatin Technologies, Inc. | 52.87% |
| Theriva Biologics, Inc. | -- |
| Oragenics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -73.23% |
| Return on Assets | -60.26% |
| Return on Invested Capital | -73.13% |
| Gross Profit Margin (Quarterly) | 96.45% |
| Operating Margin (Quarterly) | -4.61K% |
| Return on Net Operating Assets | -23.24K% |